IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE)

J Neurol Sci. 1999 Dec 1;171(1):60-4. doi: 10.1016/s0022-510x(99)00249-x.

Abstract

Blockade of the CD40 ligand (CD40L)-CD40 interaction suppresses experimental autoimmune encephalomyelitis (EAE). Since this interaction induces IL-12, an essential cytokine for EAE induction, we hypothesized that CD40L blockade may suppress EAE through IL-12 inhibition. Here we show that exogenous IL-12 abolishes the ability of anti-CD40L monoclonal antibodies to prevent EAE. Anti-IL-12 antibodies prevent this reversal and protect from EAE. These results show that IL-12 is sufficient to overcome CD40L blockade and suggest that, of the multiple consequences of the CD40L-CD40 interaction, IL-12 induction is an essential one for induction of EAE.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • CD40 Antigens / metabolism
  • CD40 Ligand
  • Crosses, Genetic
  • Encephalomyelitis, Autoimmune, Experimental / epidemiology
  • Encephalomyelitis, Autoimmune, Experimental / immunology*
  • Encephalomyelitis, Autoimmune, Experimental / metabolism
  • Encephalomyelitis, Autoimmune, Experimental / prevention & control
  • Guinea Pigs
  • Immunity, Cellular
  • Immunosuppression Therapy*
  • Incidence
  • Interleukin-12 / administration & dosage
  • Interleukin-12 / immunology*
  • Interleukin-12 / pharmacology*
  • Ligands
  • Membrane Glycoproteins / antagonists & inhibitors*
  • Membrane Glycoproteins / immunology
  • Mice
  • Mice, Inbred Strains
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects*
  • Spinal Cord / immunology

Substances

  • Antibodies, Monoclonal
  • CD40 Antigens
  • Ligands
  • Membrane Glycoproteins
  • Recombinant Proteins
  • CD40 Ligand
  • Interleukin-12